Position in CORT
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$948,972
+$768,221 QoQ
Shares Held
10,914
+110.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 92 holders
Holding Since
Dec 2020
10 quarters on record
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. CORT ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,732 | $7,814,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,893 | $1,803,901 | |
| 3 | RPRX |
Royalty Pharma plc
|
27,331 | $1,532,449 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,421 | $1,239,002 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
27,091 | $1,056,819 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
110,630 | $968,565 | |
| 7 | CORT |
Corcept Therapeutics Inc
This page
|
10,914 | $948,972 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
17,292 | $943,105 |
All Filings in CORT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $948,972 | 10,914 | Shares | Sole | 2026-07-28 | |
| 2025-12-31 | $180,751 | 5,194 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $569,054 | 6,847 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $527,966 | 7,193 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $788,917 | 6,907 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $479,964 | 9,525 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $392,732 | 8,486 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $791,001 | 24,346 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $776,708 | 30,834 | Shares | Sole | 2024-05-15 | |
| 2020-12-31 | $263,483 | 10,072 | Shares | Sole | 2022-07-28 | |
| No filing history on record for this holder in this stock. | ||||||